Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | international

COVID-19 Vaccination and Addiction Treatment (ASAM-Guidelines)

COVID-19 Vaccination and Addiction Treatment (ASAM-Guidelines)

The dissemination of effective vaccines against the COVID-19 virus is a key strategy towards controlling the COVID-19 pandemic.

People with substance use disorders are at higher risk for COVID-19 infections and serious sequalae than the general population.  In addition, higher risk is well-known to occur in populations residing in congregate housing, which can include residential and inpatient levels of care as well as housing programs serving people with addiction. 

Insufficient vaccine acceptance may promote additional virus variants and persistent transmission and illness, placing patients with addiction and their providers at ongoing risk of infection. Addiction treatment clinicians and programs play key roles in promoting access to and uptake of COVID-19 vaccine.

ASAM – American Society of Addiction Medicine, Juni 2021

https://www.asam.org/docs/default-source/covid-19/16-overcoming-vaccine-hesitancy-recommendations.pdf